Assistant Professor, Medicine, Perelman School of Medicine
Pulmonology
Dr. Scott D. Halpern, MD
Scott Halpern is an expert in the field of Pulmonology. He researched medicine at Perelman School of Medicine at the University of Pennsylvania. Scott Halpern is also published. He has 101 publications published. The lastest publication: "Default Options: Opportunities to Improve Quality and Value in Oncology.' Scott Halpern accepts Medicare payments and is listed with Medicare.gov.
Publications
- Night shifts, human factors, and errors in the ICU: a causal pathway?
- Default Options: Opportunities to Improve Quality and Value in Oncology.
- Post-Acute Care Use and Hospital Readmission After Sepsis.
- Variability Among US Intensive Care Units in Managing the Care of Patients Admitted With Preexisting Limits on Life-Sustaining Therapies.
- Supporting those who go to fight ebola.
- The Allocation of Intensivists' Rounding Time under Conditions of Intensive Care Unit Capacity Strain.
- Hospital-Based Acute Care Use in Survivors of Septic Shock.
- Are Hemodynamics Surrogate Endpoints in Pulmonary Arterial Hypertension?
- Stability of End-of-Life Preferences: A Systematic Review of the Evidence.
- Outcomes and Statistical Power in Adult Critical Care Randomized Trials.
- Improving transparency in registration of randomized clinical trials in critical care.
- An Empirical Comparison of Key Statistical Attributes Among Potential ICU Quality Indicators.
- Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans.
- ICU Occupancy and Mechanical Ventilator Use in the United States.
- Underreporting of Liver Transplant Waitlist Removals Due to Death or Clinical Deterioration: Results at Four Major Centers.
- Do windows or natural views affect outcomes or costs among patients in ICUs?
- A randomized trial of nighttime physician staffing in an intensive care unit.
- An Empirical Derivation of the Optimal Time Interval for Defining ICU Readmissions.
- Deceased organ donation consent rates among racial and ethnic minorities and older potential donors*.
- Deciphering the appropriateness of defaults: the need for domain-specific evidence.
- Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database.
- Geographic disparities in access to Lung transplantation before and after implementation of the Lung allocation score.
- Shaping End-of-Life Care: Behavioral Economics and Advance Directives.
- Validation of 6-minute walk distance as a surrogate end point in Pulmonary arterial hypertension trials.
- Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy fo...
- Deferred admission to the intensive care unit: rationing critical care or expediting care transitions?: comment on "intensive care unit bed availability and outcomes f...
- Fairness and wellness incentives: What is the relevance of the process-outcome distinction?
- Perceived inappropriateness of care in the ICU: what to make of the clinician's perspective?
- Effect of Personalization and Candy Incentive on Response Rates for a Mailed Survey of Dermatologists.
- Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver Disease era.
- ICU capacity strain and the quality and allocation of critical care.
- Race and sex differences in response to endothelin receptor antagonists for Pulmonary arterial hypertension.
- Rationing in the intensive care unit: To disclose or disguise?
- The Law, Policy, and Ethics of Employers' Use of Financial Incentives to Improve Health.
- The Societal Impact of Single Versus Bilateral Lung Transplantation for Chronic Obstructive Pulmonary Disease.
- Financial Incentives for Research Participation: Empirical Questions, Available Answers and the Burden of Further Proof.
- Relationship Between Treatment Preference and Weight Loss in the Context of a Randomized Controlled Trial.
- Rule of rescue or the good of the many? An analysis of physicians' and nurses' preferences for allocating ICU beds.
- Informed consent for organ-donor management research: Antemortem or postmortem human research.
- Current trends in living donor liver transplantation for primary sclerosing cholangitis.
- Longer-Term Outcomes After Kidney Transplantation From Seronegative Deceased Donors at Increased Risk for Blood-Borne Viral Infection.
- Lottery-Based versus Fixed Incentives to Increase Clinicians' Response to Surveys.
- Informed consent in research to improve the number and quality of deceased donor organs.
- Shaping patients' decisions.
- Estimated supply of organ donors after circulatory determination of death: a population-based cohort study.
- Survival differences following Lung transplantation among US transplant centers.
- A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 Influenza pandemic.
- Beneficent persuasion: techniques and ethical guidelines to improve patients' decisions.
- Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection.
- The future of the orthopaedic clinician-scientist: part II: Identification of factors that may influence orthopaedic residents' intent to perform research.
- Regulated payments for living kidney donation: an empirical assessment of the ethical concerns.
- Organ donors after circulatory determination of death: not necessarily dead, and it does not necessarily matter.
- No child left behind: Enrolling children and adults simultaneously in critical care randomized trials.
- Patients as mercenaries?: the ethics of using financial incentives in the war on unhealthy behaviors.
- Misclassification of Pulmonary hypertension due to reliance on Pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure.
- Utility of the Systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies.
- The ethics of randomized clinical trials in Pulmonary arterial hypertension.
- Informing candidates for solid-organ transplantation about donor risk factors.
- Nonconsented human immunodeficiency virus testing among critically ill patients: intensivists' practices and the influence of state laws.
- Harnessing the power of default options to improve health care.
- Development of an e-mail database of US intensive care physicians.
- Terminal withdrawal of life-sustaining supplemental oxygen.
- Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons: prevalence, correlates, and implications.
- Evidence-based equipoise and research responsiveness.
- Decisions devoid of data?
- HIV testing without consent in critically ill patients.
- Re: "Ethics and sample size".
- Post-call accidents.
- Willingness of patients to switch from conventional to daily hemodialysis: looking before we leap.
- Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials.
- Preevent vaccination against smallpox: a survey of pediatric emergency health care providers.
- Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysis.
- Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.
- Response to Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
- Smallpox vaccination: a national survey of emergency health care providers.
- Reporting enrollment in clinical trials.
- Physicians' preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs.
- Randomized trial of 5 dollars versus 10 dollars monetary incentives, envelope size, and candy to increase physician response rates to mailed questionnaires.
- Solid-organ transplantation in HIV-infected patients.
- The continuing unethical conduct of underpowered clinical trials.
- Prospective preference assessment: a method to enhance the ethics and efficiency of randomized controlled trials.
- Health care waste management: a neglected and growing public health problem worldwide.
- Commitment contracts as a way to health.
- Taking DNA from the dead.
- Research recruitment via camouflaged sampling: addressing the legal and ethical aspects of privacy concerns.
- Re-examining ethical obligations in the intensive care unit: HIV disclosure to surrogates.
- Determinants of transplant surgeons'' willingness to provide organs to patients infected with HBV, HCV or HIV.
- Towards evidence based bioethics.
- Adding nails to the coffin of underpowered trials.
- Epidemiologic studies of adverse effects of anti-retroviral drugs: how well is statistical power reported.
- Incentive models to increase living kidney donation: encouraging without coercing.
- Commentary: Improving response rates to mailed surveys: what do we learn from randomized controlled trials?
- Evaluating preference effects in partially unblinded, randomized clinical trials.
- Who will enroll? Predicting participation in a phase II AIDS vaccine trial.
- Delay in recognition of Pulmonary arterial hypertension: factors identified from the REVEAL Registry.
- Transplantation of kidneys from donors at increased risk for blood-borne viral infection: recipient outcomes and patterns of organ use.
- Placebo-controlled trials are unethical in clinical Hypertension research.
- Declining rate of substance abuse throughout the month.
- Informing patients of uncertainty in clinical trials.
- Minute ventilation recovery time measured using a new, simplified methodology predicts extubation outcome.
Schools
Perelman School of Medicine University of Pennsylvania
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Atelectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Education
-
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Hospital of the University of Pennsylvania -
Penn Presbyterian Medical Center
Drug Facts
| NPI NUMBER | 1639232143 | |
| NPPES Provider LastName | HALPERN | |
| NPPES Provider FirstName | SCOTT | |
| NPPES Provider ZIPCode | 191044206 | |
| NPPES Provider State | PA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 117.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639232143 |
| Last Name Of The Provider | HALPERN |
| First Name Of The Provider | SCOTT |
| View All |
Similar Doctors
|
Mehmood A. Durrani, MB
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pramod B. Krishnamurthy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary Elizabeth Kreider, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Benjamin, MD |
|
|
Dr. Peter C. Serpico, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan L. Gelfand, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard D. Shusterman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Salvatore Mangione, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert S. Grossman, MD |
|
|
Dr. William P. Sexauer, MD
This Doctor is OpenDoctor Recommended.
|